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Purpose: There is a bidirectional link between uncontrolled diabetes and untreated 
periodontal disease. Controlling periodontal infection plays an essential role in the overall 
management of diabetes. This study explored an interprofessional (IP) collaboration 
between Certified Diabetes Care and Education Specialists (CDCES) and Dental 
Hygienists and the utility of a point of care Periodontal Screening Tool (PST) for CDCES 
to build confidence in informing their clients on periodontal disease risk factors and 
providing resources to seek dental care.  
Methods: This pilot study used a pre-test post-test design where a survey was 
administered prior to CDCES participating in an Education and Training Module on the 
oral systemic link, periodontal risk factors, and instruction for the PST.  A post-survey 
two weeks after module participation and use of the PST was administered with similar 
pretest items as well as qualitative items.   
Results: Pre- and post-test scores for participants (n=4) in this pilot study suggests the 
use of the PST with an IP Education and Training Module resulted in the CDCES’ increased 
confidence in informing the patient about periodontal disease risk factors and providing 
resources to seek dental care. All of the CDCES (100%) reported using the Periodontal 
Screening Tool increased their confidence in recommending patient for dental care. 
Although, the sample size could not attain significance, findings support this pilot study 
is feasible. 
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Conclusion: An IP collaboration and Periodontal Screening Tool for CDCES could 
translate to individuals with poorly controlled diabetes seeing the dentist or dental 
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Introduction/Literature Review 
Introduction to the Research Question   
Diabetes affects an estimated 422 million adults worldwide (World Health 
Organization [WHO] Global Report on Diabetes, 2016). Periodontal disease is the sixth 
most common complication of diabetes (Loe, 1993). As reported in the current American 
Academy of Periodontology [AAP] Fact Sheet (2019), half of Americans 30 years of age 
and older have periodontitis, a severe form of periodontal disease affecting an estimated 
64.7 million Americans. The overarching message from the Office of the Surgeon 
General states oral health is essential to the general health and well-being of all 
Americans (Surgeon General Priority: Oral Health, 2019). 
A landmark study by Shlossman, Knowler, Pettit, & Genco (1990) explored the 
relationship between oral health and systemic diseases. The relationship between oral 
health and systemic diseases, such as cardiovascular disease and diabetes, continues to be 
explored and is referred to as the oral-systemic link (Genco & Williams, 2010; Joseph, 
Kullman, & Sharma, 2016). Researchers speculate inflammation may be the basis for this 
connection and call for additional research to better understand how treating periodontal 
disease may reduce the risk of developing and/or worsening complications from 
inflammatory diseases.  
Registered Dental Hygienists (RDH) are specifically educated in assessing, 
diagnosing, treating, and evaluating periodontal disease. Certified Diabetes Care and 
Education Specialists (CDCES) provide education, support, and care management for the 
diabetic patient. They advocate for individuals with diabetes by promoting self-
2 
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management to achieve behavioral and treatment goals to minimize risk and optimize 
health outcomes. Both RDH and CDCES are essential in treating and managing patients 
with diabetes. With the increased risk factors associated with diabetes it, is important to 
include an educational screening tool for periodontal risk factors as part of inter-
professional collaborative care.  
Statement of Problem  
Diabetes and periodontal disease are common but complex conditions. The 
number of Americans with diabetes is projected to double or triple by 2050 (American 
Association of Diabetes Educators [AADE], 2017). Periodontal disease is prevalent in 
both developed and developing countries and affects an estimated 20-50% of global 
populations (American Academy of Periodontology [AAP] Fact Sheet, 2019). 
Periodontal disease is prevalent in adolescents, adults, and geriatric individuals, making it 
a public health concern (Nazir, 2017). There is an increased risk in prevalence and 
severity of periodontal disease in individuals with poorly controlled diabetes (Tandon et 
al., 2015; Molina et al., 2016; Zuikaite, Slot, & Van der Weijden, 2018). The 
bidirectional relationship between diabetes and periodontal disease and the mechanism by 
which this occurs remains the topic of ongoing research (Chapple & Genco, 2013; 
Casanova, Hughes, & Preshaw, 2014; Agarwal, Chaubey, Mada, & Agarwal, 2016; 
Fatima et al., 2017). The inference can be made that individuals with diabetes are likely 
to have periodontal disease and vice versa. The treatment of periodontal disease may 
contribute to improvements in health, not only in the oral cavity but throughout the body 
(Sabharwal et al., 2018). 
3 
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Conventional non-surgical periodontal therapy may help reduce and control 
glycemic levels (HbA1c). The term HbA1c refers to a blood test that indicates the 
presence of excessive sugar in the bloodstream over a three-month period. Similarly, 
improved glycemic control may help improve periodontal disease. Considering the 
potential impact of periodontitis on HbA1c, thus increasing the risks of other diabetic 
complications, it is important to include the treatment of periodontal disease as an 
integral element of diabetes care. Based on this, coordination between CDCESs, who are 
experts in diabetes management, and dentists and dental hygienists, who are experts in 
periodontal disease, is necessary. Providing a tool for periodontal disease risk assessment 
for CDCES could translate to individuals with poorly controlled HbA1c seeing the dentist 
or dental hygienist for evaluation and treatment. Results from this study could contribute 
to interprofessional education and collaboration among all care providers of the diabetic 
patient (ADHA Research Agenda, 2016).  
Research Questions 
There is a gap in the research regarding the utility of a Periodontal Screening Tool 
for non-dental health care providers. To address this deficiency, this proposed study seeks 
to answer the following questions:  
• Does a Periodontal Screening Tool, accompanied by training on how to 
use this tool, increase CDCES’s confidence in informing the patients on 
periodontal disease risk factors? 
• Does the CDCES’s confidence result in their providing resources for their 
patients to seek dental care? 
   
4 
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Overview of Research  
 This study explored how diabetes and periodontal disease are related and how the 
treatment of one affects the other. It investigated interprofessional collaboration between 
the medical and dental communities, specifically CDCES and RDH, as well as offered a 
possible solution in connecting healthcare providers in support of each other in providing 
total patient care. 
Diabetes 
 The American Diabetes Association [ADA] (2016) describes diabetes as a 
pathological consequence of physiological changes resulting in metabolic dysregulation, 
hyperglycemia, and chronic inflammation. Diabetes mellitus, commonly known as 
diabetes, is a chronic systemic disease that occurs when the pancreas does not produce 
enough insulin (a hormone that regulates blood sugar) or when the body cannot 
effectively use the insulin produced or the insulin produced is defective. Insulin is a 
hormone that moves glucose (sugar) from the blood into the cells to be stored or used for 
energy. It regulates blood glucose by allowing cells to absorb and use glucose, which 
lowers blood glucose levels (A1C). If the amount of insulin available is insufficient, cells 
respond poorly to the effects of insulin. This is known as insulin resistance. If the insulin 
itself is defective, glucose is not absorbed properly or stored appropriately by the body 
cells that require it. When this occurs, the net effect is persistently higher than normal 
levels of blood glucose, poor protein synthesis, and other metabolic derangement. 
Deficiency of insulin or the insensitivity of its receptors is at the center of all forms of 
diabetes (Little et al., 2018) (see Figure 1). 
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Figure 1 
Deficiency of Insulin and Diabetes 
 
Note. The net effect of defective insulin, insufficient insulin, and/or insulin resistance 
 Specific types of diabetes include Type 1, Type 2, Genetic Defects of the B-cell, 
Diseases of the Exocrine Pancreas, Endocrinopathies, Drug or Chemical-Induced 
Diabetes, Infections, and Gestational. There are also several uncommon forms of 
immune-mediated and genetic syndromes sometimes associated with diabetes. Currently, 
in the United States 30.3 million people have been diagnosed with diabetes and 84.1 
million people are considered prediabetic. Diabetes typically presents as Type 1 or Type 
2, the latter accounts for 90-95% of diagnosed cases (American Association of Diabetes 
Educators [AADE], 2017). 
 Type 1 diabetes (DM1) is an autoimmune response in which the pancreas no 
longer produces insulin to control blood sugar. The immune system mistakenly attacks 
and destroys insulin-producing beta cells in the pancreas. To avoid hyperglycemia (too 
much) or hypoglycemia (too little blood sugar), individuals with DM1 must be managed 
with insulin injections to help their bodies use glucose efficiently. For this reason, DM1 
is also referred to as insulin-dependent diabetes mellitus or juvenile diabetes (Little et al., 
2018). 
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 Type 2 diabetes (DM2) begins with insulin resistance, a condition where cells 
cannot effectively use the insulin the pancreas produces. The most common cause for 
developing DM2 is a combination of obesity and insufficient exercise. In the beginning 
stages, extra insulin is produced, causing the blood glucose to rise higher than normal 
(hyperglycemia). Over time insulin production is less than ideal, resulting in unhealthy 
fluctuations in blood sugar (glucose) levels. This condition is managed with medication 
with or without insulin (Little, et al., 2018). 
 Several methods are used to diagnose diabetes. Diagnosis of diabetes is 
determined daily by measuring fasting levels of serum glucose (A1c) and levels of 
glycosylated hemoglobin over a 2-3-month period (HbA1c). The ADA, (2016), 
recommends the following criteria for the diagnosis of diabetes: HbA1c > 6.5%, fasting 
plasma glucose > 126mg/dl, random plasma glucose > 200mg/dl, and two-hour plasma 
glucose > 200mg/dl. (see Table 1). 
Table 1 











Performed in laboratory by method NGSP-
certified and standardized to DCCT assay 
 





At least eight-hour fast 
  





In persons with symptom of hyperglycemia or 
hyperglycemic crisis: Blood glucose measured 
at any time of day  
 






Following a glucose load of 75 g anhydrous 
glucose dissolved in water 
 
  > 200mg/dl 
Adapted from ADA, (2016). 
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 The ADA lists the following long-term complications associated with DM2: 
retinopathy (eyes), neuropathy (nerve damage), nephropathy (kidney), cardiovascular 
disease (heart), peripheral vascular disease (arteries), and periodontal disease (oral 
cavity). Individuals with DM2 are also prone to infection and experience slow wound 
healing (ADA Diabetes Management Guidelines, 2016). In addition to periodontal 
disease, oral complications associated with diabetes may include salivary dysfunction 
(xerostomia or dry mouth), bacterial, viral, and fungal infections (including candidiasis), 
neurosensory disorders (burning mouth syndrome), increased incidence and severity of 
dental caries, and periapical abscesses (Little et al, 2018).  
  Two of the biggest challenges for individuals with DM2 are stable glucose levels 
at the time the blood is sampled and maintaining stable HbA1c glucose levels. The 
normal range for HbA1c is between 4% and 5.6%. Individuals with DM2 have HbA1c 
levels of 6.5% or higher. The higher the glucose concentration in the blood, the higher the 
detectable hemoglobin (ADA, 2016) (see Figure 2). Unstable or uncontrolled glucose 
levels increases the risks associated with diabetes. The successful management of these 
complications has been shown to have a positive impact on the quality of life (QoL.) for 
the diabetic individual (Mizumo et al., 2017). 
Complications from diabetes have a fiscal impact as well. Economic loss due to 
the complications of diabetes affects individuals and their families, health systems, and 
national economies through direct medical costs and loss of work and wages (World 
Health Organization [WHO] Global Report on Diabetes, 2016). The global economic 
burden is estimated to increase in the United States from $1.3 trillion in 2015 to $ 2.1 
trillion by 2030 (Bommer et al., 2018). 
8 




Levels of Control and Numerical Ranges for HbA1c or A1c 
HbA1c % 
 











































Greater than 160mg/dl 
 
 Diabetes Treatment and Management. Hyperglycemia is at the center of 
diabetes treatment. Treatment protocol is determined by a medical doctor and is dictated 
by the needs of the individual patient. DM2 treatments include diet, exercise, medication, 
and insulin therapy. Because obesity is a contributing factor in developing and managing 
diabetes, physical activity level (exercise), nutrition (healthy eating and portion control), 
and community support for weight loss is prescribed and is often under the supervision of 
a registered dietitian and exercise specialist. When life-style changes (diet and exercise) 
are ineffective in controlling blood glucose levels, medications with or without insulin 
are prescribed as an adjunct (ADA, 2020). Oral medications are the first kind of medicine 
prescribed in the treatment of DM2 when diet and exercise are not enough (see Figure 3). 
Insulin therapy is prescribed when oral medications alone are ineffective controlling 
HbA1c. Types of insulin are grouped according to how fast they work and how long the 
effects last (see Table 2). 
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Type 2 Diabetes Oral Medications  






• Blocks enzymes that 
help digest food  






• Raises level of 
dopamine 
• Helps improve blood 
glucose control  
Biguanides  Metformin (Fortamet, 
Glucophage, Glucophage XR, 
Glumetza, Riomet) 
• Improves the ability of 
insulin to move glucose 
into cells, especially 
muscle 
DPP-4 inhibitors  Aloglipitin (Nesina) 
Linagliptin (Tradjenta)  
Saxagliptin (Onglyza) 
Sitagliptin (Junuvia) 
• Signals the pancreas to 
release insulin  
• Boosts insulin levels 
when blood glucose is 
too high 
• Signals liver to cut back 
on glucose production  
SGLT2 inhibitor Canagliflozin (Invokana) 
Dapagliflozin (Farxiga) 
Empagliflozin (Jardiance) 
• Increases amount of 
glucose in urine 
• Blocks kidneys form 
reabsorbing glucose 





Micronase, Glynase Pre Tab) 
Glipizide (Glucotrol, Gluterol 
XL) 
• Prompts pancreas to 
release insulin  
• Helps body use insulin 
efficiently  
Meglitinides Nateglinide (Starlix) 
Repaglinide (Prandin) 
• Boosts insulin release 
from pancreas when 




Colesevelam (Welchol) • Lowers cholesterol 
• Lowers blood glucose  
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Injectable Insulin Therapy 
 
TYPE ONSET PEAK DURATION 
Rapid Acting 15 minutes  At 1 hour 2-4 hours 
Regular or 
Short-Acting 
Within 30 minutes 2-3 hours 3-6 hours  
Intermediate-Acting 2-4 hours  4-12 hours 12-18 hours 
Long Acting 2 hours Lowers glucose levels nearly 
evenly over 24-hour period 
  
Individuals with diabetes must learn to manage their disease through diabetes 
self-management training that includes glucose monitoring, adjustments in diet and 
exercise, taking medication as directed, returning periodically to see the physician as 
recommended, and seeing the dentist or hygienist for a periodontal evaluation. 
Periodontal Disease 
 Periodontal disease is prevalent in adolescents, adults, and geriatric individuals 
making it a public health concern (Nazir, 2017). It is estimated by the American 
Association of Periodontology (AAP) 64.7 million Americans have periodontal disease, 
defined as an inflammatory disease affecting the soft tissues (gingiva) and bone that 
support the teeth (AAP Fact Sheet, 2018). Moderate periodontitis in adults is estimated to 
affect 40-60% worldwide (Chapple & Genco, 2013).  
 Several factors influence the severity of periodontitis and contribute to 
progression including poor oral hygiene, age, diet, genetic susceptibility, and 
medications. Local factors such as poorly placed and/or ill-fitting crowns or fillings 
promote gingival inflammation and clinical attachment loss. Smoking and stress are 
environmental factors that decrease host immune function, resulting in increased 
11 
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susceptibility to disease. Systemic diseases, such as diabetes and cardiovascular disease, 
can alter host defense mechanisms and deregulate the inflammatory response, resulting in 
a decrease in host defense to bacterial infection (Genco & Williams, 2010). 
 Gingivitis and Periodontitis. Periodontal disease has two stages: gingivitis and 
periodontitis. Gingivitis occurs when the body recognizes the bacterial biofilm (dental 
plaque) as harmful or foreign. Dental plaque is a biofilm of soft, sticky, colorless 
bacterial colonies that adhere to the tooth surface above the gumline (supragingival) and 
below (subgingival). The bacteria located within the infected gingiva are pathogenic, 
highly inflammatory, and able to survive in the blood stream and thus contribute to 
infection in other areas of the body (Poudel et al, 2018). Dental plaque is unique to the 
individual and although it cannot be eliminated, it can be reduced and controlled with 
regular and thorough brushing and flossing. In some individuals, dental plaque can 
mineralize due to an exchange of calcium and phosphate ions present in saliva, forming a 
hard deposit called calculus. Calculus can be subgingival or supragingival (Walsh,2020). 
Once calculus forms, the toothbrush, dental floss, and/or oral hygiene aids are ineffective 
at removing it. The successful removal of calculus can only be accomplished by a dentist 
or dental hygienist, typically in a clinical setting.  
 In reaction to dental plaque, the inflammatory response is activated. The blood 
vessels dilate, becoming too fragile to accommodate an increase in clean-up cells, called 
macrophages and phagocytes, to fight the infection. The gingiva is red, swollen, and 
bleeds easily. At this point, the process is reversible with the mechanical removal of the 
dental biofilm and calculus. If not reversed or interrupted, gingivitis may progress to 
periodontitis, which is irreversible. In this reaction, inflammatory mediators, including 
12 
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interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-a), prostaglandins, and cytokines 
are stimulated, which results in damage to the underlying bone support (Grossi & Genco, 
1998; Mesia et al., 2016; Dogan et al, 2016). This in turn results in a periodontal pocket 
measurable with a periodontal probe (see Figure 4). If not arrested, further destruction 
occurs, resulting in bone loss that can be seen on a dental radiograph or x-ray (see Figure 
5). Extensive bone-loss causes the teeth to loosen and eventually fall out (AAP, 2018). 
Figure 4 
The Progression of Periodontal Disease 
 
  
Darling-Fisher et al., (2015). DOI: https://doi.org/10.1016/j.nurpra.2015.08.001 
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Figure 5 
Periodontal Disease and Destruction/Bone Loss 
Used with permission https://doi.org/10.1038/ki.2008.660  
Note. Figure 5 is two-part: Diagram (a) is a graphic depicting a tooth with healthy 
cementum, connective tissue, and alveolar (jaw) bone on the left side and compromised 
due to periodontal disease on the right side. Diagram (b) illustrates a radiographic image 
of optimal bone support on the left side and bone loss on the right.  
The dentist, periodontist, or dental hygienist performs a periodontal examination 
to determine the presence and extent of periodontal disease, consider the cause, and plan 
treatment accordingly (AAP, 2018).  
Based on a model of staging and grading, with the addition of smoking and 
diabetes as modifiable risk factors, a universal classification system for periodontitis was 
developed as part of the 2017 World Workshop on periodontal disease (Papanous et al., 
2018). The concept of staging has been extensively developed in the field of oncology. 
Staging of tumors is based on current observable clinical presentation, including severity 
and extent of disease and considers complexities of case management. To supplement 
staging, grade is used to assess the potential for tumor progression. In addition, molecular 
14 
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markers often guide drug therapies, and thereby incorporate biological targets, thus 
increasing the probability for favorable outcomes (Tonelli, et al., 2018).  
 Figures 6 and 7 depict the Universal Classification System for Periodontitis based  
on stage and grade. Staging is largely dependent upon the severity of disease according to 
the level of interdental clinical attachment loss (CAL), radiographic bone loss and tooth 
loss, extent, and distribution as well as the anticipated complexity of disease management 
(Papanous et al., 2018). The goals of staging periodontitis are 1) to classify severity and 
extent of disease based on currently measurable content of destroyed and damaged tissue 
and 2) to assess specific factors that may determine complexity of controlling current 
disease and managing long-term function and esthetics of dentition (Tonelli et al., 2018). 
 Grading is used as an indicator of the rate of periodontitis progression: slow, 
moderate, or rapid. Grade is established based on direct evidence (radiographic bone loss 
or CAL) or indirect evidence (% of bone loss/age and/or case phenotype) of progression. 
Once grade is established based on evidence of progression, it can be modified based on 
the presence of two modifiable risk factors: smoking (<10 cigarettes/day or >10 
cigarettes/day and diabetes (HbA1c <7.0% or HbA1c >7.0%). Grading provides 
supplemental information, including anticipated treatment responses or outcomes and 
effects on systemic health (Papanous, 2018). The purpose for grading periodontology is 
two-fold: 1) To estimate future risk for disease progression and responsiveness to 
treatment and to guide intensity of therapy and monitoring and 2) to estimate the potential 
health impact of periodontitis on systemic disease and to guide systemic monitoring and 
co-therapy with medical colleagues (Tonelli, et al., 2018).
15 
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Figure 6  
Staging of Periodontitis 
 
Tonelli, Greenwall, & Kornman DOI: 10.1002/JPER.18-0006 
 
Figure 7  
 
Grading of Periodontitis 
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Role of the Dental Hygienist in Periodontal Therapy. Periodontal therapy is the  
mechanical removal or debridement of calculus performed by a dental hygienist. A dental 
hygienist is a licensed dental professional who specializes in the health of the mouth (oral 
cavity). They are educated in accordance with the Commission on Dental Accreditation 
(CODA) standards and tested at the national and state levels. Unlike a dental assistant 
who can “clean” above the gumline, a dental hygienist is licensed to “clean” below the 
gumline. This is a non-surgical procedure called scaling and root planing (SRP) and is 
typically done with local anesthetic to ensure patient comfort. Equally important is the 
role of empowering the patient in the care of their oral cavity as it relates to the overall 
health of their body and enrolling them in regularly scheduled periodontal maintenance 
therapy following scaling and root planing. Patient compliance with periodontal 
maintenance therapy is imperative in keeping periodontal disease controlled.  
Periodontal Therapy and Glycemic Control. Many studies address the effect of 
periodontal therapy on glycemic control. For example, Simpson et al., (2015) conducted a 
Systemic Review of the literature to investigate the effect of periodontal therapy on 
glycemic control in people with DM2. This review of existing clinical trials conducted 
through December 2014 was carried out by the authors working with the Cochran Oral 
Health Group and updates the previous version published in 2010. The authors propose 
two broad comparisons: 1) Periodontal therapy (SRP) versus usual care/no active 
intervention and 2) SRP versus alternative therapy. The authors conclude from 14 trials 
(n= 1499) SRP reduces HbA1c in patients with DM2 by 0.29% up to 4 months when 
compared with no active intervention/usual care. And after 6 months (five studies (n= 
826) there was no evidence this reduction was sustained. The researchers found from 21 
17 
PERIODONTAL RISK FACTOR EVALUATION TOOL 
 
studies (n= 920), no evidence that one periodontal therapy was more effective than 
another in improving HBA1c in individuals with DM2. Due to the limitations of the 
studies included in this review, the authors call for randomized clinical trials (RCTs) with 
larger number of participants and longer follow-up periods. In addition to RCTs, the 
authors call for future research to determine whether adjunctive drug therapies should be 
used with periodontal treatment. 
 Similar research was conducted in 2017 by Mauri-Obradors et al. A 6-month 
single-masked, randomized clinical trial was undertaken to evaluate the effect of non-
surgical periodontal treatment on HbA1c levels in patients with DM2. A total of 90 
subjects with HbA1c levels 7.7% with generalized chronic periodontitis were randomly 
assigned to a treatment group (n= 42) or a control group (n= 48). The treatment group 
(n= 42) received oral hygiene instruction plus subgingival (below the gumline) non-
surgical removal of dental plaque and calculus (scaling and root planing). The control 
group (n= 48) received oral hygiene instruction plus supragingival (above the gumline) 
removal of dental plaque and calculus. The findings report an improved periodontal 
status and significant improvement (p< 0.05) in HbA1c control 6-months after non-
surgical periodontal treatment, while the periodontal status and HbA1c control in the 
control group remained unchanged. The researchers call for future randomized clinical 
trials with longer term follow-up and larger number of participants to confirm the current 
evidence. 
 Perhaps the most powerful evidence supporting the hypothesis that periodontal 
therapy reduces HbA1c comes from a study conducted by Merchant et al., (2016). 
Unique to this study is the number of participants (n=126,805) and the follow-up period 
18 
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of 1.7 years. The purpose of this research was to evaluate the impact of long-term 
treatment of periodontal disease on glycemic control in a large cohort of individuals 
(n=126,805) with DM2 receiving care at Veterans Administration medical centers in the 
United States from 2005 through 2012. The exposures were periodontal treatment at 
baseline and at follow-up maintenance appointments. The outcome was change in HbA1c 
following initial and follow-up treatment. Diabetes control was defined as HbA1c at <7% 
and <9% following initial and follow-up treatment. Results from this study indicate that 
long term periodontal therapy reduces HbA1c (-0.25%) and increases the probability of 
controlling diabetes by 13% at both HbA1c <7% and HbA1c <9% cutoffs. At the same 
time, the benefits of periodontal treatment are greater in this group of individuals 
compared to those with lower HbA1c levels at baseline (p<0.05). This finding is 
clinically meaningful because even a 1% reduction in HbA1c has been shown to reduce 
diabetes complications. The United Kingdom Prospective Diabetes Study (UKPDS) data 
shows for each 1% reduction in HbA1c, the relative risk for diabetes-related deaths 
decreases by 21% (p<0.0001), microvascular complications decrease by 37% (p<0.0001), 
and myocardial infarction decreases by 14% (p<0.0001) (Stratton et al., 2000). 
 On the contrary, in a 6-month randomized clinical trial, Mizumo et al., (2017), 
investigated the effects of SRP on HbA1c, oxidative stress balance and quality of life 
(QoL) in patients with DM2 compared to no periodontal treatment. Participants with both 
DM2 and chronic periodontitis were assigned to a treatment group or a control group. 
The treatment group (n=20) received SRP plus oral hygiene instruction (OHI) and 
consecutive periodontal maintenance therapy at 3 and 6 months. The control group 
(n=17) received only OHI without treatment during the 6-month experimental period. 
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The primary study outcome was the change in HbA1c levels form baseline to 3 months. 
Secondary outcomes included changes in oxidative stress balance (Oxidative-INDEX), 
the Diabetes Therapy-Related QoL, and clinical periodontal parameters from baseline to 
3 month and baseline to 6 months. The authors conclude that SRP improves systemic 
oxidative stress balance and QoL and results show a modest but not significant reduction 
in HbA1c levels (p=0.070). The researchers discuss how improvements in periodontitis 
may contribute to better QoL for individuals with diabetes. They report QoL scores 
(satisfaction with diabetes treatment) improved after periodontal treatment and suggest 
this may contribute to compliance. 
 The successful treatment of periodontitis reduces inflammation which, 
theoretically, could influence HbA1c in individuals with poorly controlled DM2. Based 
on this information, controlling periodontal infection plays an essential role in the overall 
management of DM2. 
The Oral-Systemic Link 
  
 The oral-systemic link is the connection between oral health and overall health. 
The concept of the oral-systemic relationship has evolved over the years. As far back as 
the Middle Ages, the oral cavity was repeatedly implicated as the origin of human 
illnesses and diseases. It was suspected an inter-relationship existed between oral disease 
and systemic conditions (Genco & Williams, 2010). The literature demonstrates 
increasing evidence regarding the relationship between oral disease and systemic diseases 
such as diabetes and cardiovascular disease (Lamster, Lalla, Borgakke, & Taylor, 2008; 
DeRossi, 2012; Joseph, Kullman, & Sharma, 2016; Cardoso, Reis, & Manzanares-
Cespedes, 2018). As early as 1998, research conducted by Grossi and Genco 
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demonstrates this bidirectional relationship, suggesting diabetes affects periodontal 
disease and vice versa (see Figure 8).  
Figure 8  
 
Proposed Bidirectional Relationship 
 
Adapted from  https://doi.org/10.1902/annals.1998.3.1.51 
 
 Early research conducted by Shlossman, Knowler, Pettit, and Genco (1990) 
studied the relationship between periodontitis and diabetes and laid the groundwork for 
future studies to investigate whether diabetes is a risk factor for developing periodontal 
disease. A landmark study by Taylor, Burt, Becker, Genco, & Shlossman (1996) found 
patients with DM2 and periodontitis were more likely to develop difficulties in 
maintaining a healthy HbA1c than diabetic patients without periodontitis. The 
bidirectional relationship is further established in a cross-sectional study involving 40 
subjects aged 35-45 years with DM2 and periodontitis, conducted by Tandon et al., 
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(2015). These findings demonstrate an increased prevalence and severity of periodontitis 
in individuals with uncontrolled HbA1c. The researchers speculate the “poorer the 
control and longer the duration of diabetes, the greater will be the prevalence and severity 
of periodontal disease” (p. 300). This concept was also explored by Fatima et al. (2017), 
who assessed the effect of uncontrolled diabetes on the health of the periodontium and 
concluded the bidirectional relationship between periodontitis and diabetes can be 
“explained in terms of glycemic control and severity of periodontitis” (p. 292).  
Additionally, Tsau, Hayes, and Taylor (2002), investigated the association between 
HbA1c and periodontitis in patients (N= 4,343) between the ages of 45 and 90. After 
controlling for age, education, smoking status, and calculus, the authors conclude that 
individuals with HbA1c > 9% had a significantly higher prevalence of severe 
periodontitis than those without diabetes (odds ratio = 2.90; 95% CI: 1.40, 6.03). It was 
also noted the pervasiveness of DM2 with periodontitis was nearly twice that of patients 
without periodontitis. It is becoming increasingly clear that oral infection has a systemic 
effect. The bacteria within the infected gingiva (periodontal pocket) are disease causing, 
highly inflammatory, and able to survive in the blood stream and, thus, intensify 
inflammation in other areas of the body (Poudel et al., 2018).  
 Subsequent studies explore the relationship between periodontal disease and 
diabetes to further investigate the bidirectional link (Preshaw, et al., 2012; Casanova, 
Hughes, & Preshaw, 2014; Molina et al., 2016; Dogan, Dede, Balli, & Sertoglu 2016). 
The mechanisms linking these entities is not fully understood; however, emerging 
evidence suggests inflammation may be the basis of this connection. 
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 Fundamental Linkage. Periodontitis and DM2 each exhibit increased 
inflammatory response involving similar biological mediators called cytokines. The role 
of cytokines is cell to cell communication. DM2 can increase the activity of inflammatory 
mediators within areas affected by periodontal disease. Bacterial invasion of the gingiva, 
as seen in periodontitis, stimulates the formation of inflammatory mediators such as 
interleukin-1 (IL-1), interleukin-6 (Il-6), tissue necrosis factor-a (TNF-a), and 
prostaglandins. These inflammatory mediators lead to the production and activation of 
enzymes that destroy gingival connective tissue and destroy bone (Bozhurt, et al., 2016). 
With persistent hyperglycemia, as seen in DM2, advanced-glycated end-products are 
produced, resulting in the production and release of reactive oxygen species and 
proinflammatory mediators such as IL-1, IL-6, and TNF-a.  These stimulate an 
exaggerated inflammatory reaction, resulting in periodontal tissue destruction with 
limited tissue repair (Sabharwal, Gomes-Filho, Stellrecht, & Scannapieco, 2018).  
 This connection is further substantiated in a review of the literature conducted by 
Cardoso, Reis, & Manzanares-Cespedes (2018), focusing on inflammatory cytokines 
present in uncontrolled DM2 and chronic periodontitis. The results of this study reveal 
both diseases exhibit an overproduction of proinflammatory mediators, such as IL-1, IL-
6, and TNF-a suggesting a “fundamental linkage” (101). The authors conclude the 
overproduction of proinflammatory cytokines exacerbates the destruction of the 
supporting soft and hard tissue surrounding the teeth.  
 Consistent with this finding, in a case-control study conducted by Mesia et al., 
(2016), participants (N=20) with moderate to severe periodontal disease were divided 
equally into two groups: those with DM2 and those without. The purpose of this study 
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was to quantify immune responsiveness in individuals with and without DM2. Although 
this study did not directly evaluate inflammation, the results demonstrated higher levels 
of IL-1, IL-6, and TNF-a in the group with moderate periodontitis and DM2 (see Figure 
9). 
Figure 9  
Proposed Fundamental Linkage 
 
 
Note. Periodontitis and uncontrolled DM2 are inflammation-driven, thus contributing to 
the destruction of the hard and soft tissues of the periodontium. 
  
 Perhaps the most convincing evidence of the fundamental linkage comes from a 
review of the literature conducted by Polak and Shapira (2018). The purpose of this 
review is to evaluate current evidence of the mechanism that may link periodontitis and 
diabetes. The study is based on a review conducted by Taylor et al., (2013) with the 
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addition of research from June, 2012, through November, 2016. This search resulted in 
831 publications. Title screening resulted in 256 articles with relevant topics. Abstract 
screening (excluding pregnancy diabetes articles) resulted in 35 reviews, 40 animal 
studies, and 99 human studies. Studies were screened and evaluated according to the 
level of diabetes control, as defined in each study. The results were divided according to 
the following scientific topics: 1) Biological plausibility (proposal of a causal 
relationship) of increase in severity of periodontitis in patients with diabetes 2) Biological 
plausibility of the effect of periodontitis on diabetes control, and 3) Biological 
plausibility of the effect of treatment of periodontitis on diabetes control. The results of 
this study indicate a possible association between HbA1c and changes in the periodontal 
bacteria, with no causal relationships. Clinical and animal studies found elevated gingival 
levels of IL-1, IL-6, TNF-a in poorly controlled diabetes and individuals with diabetes 
and periodontitis exhibit high-levels of circulating TNF-a. In addition, successful 
periodontal treatment reduces their levels.  
 The authors conclude poorly controlled HbA1c levels may aggravate 
periodontitis. Some evidence suggests the systemic inflammation, resulting from 
periodontitis, has the potential to affect diabetes control. However, they found no studies 
addressed the impact of successful periodontal therapy on the mechanisms involved in 
systemic complications of diabetes.   
 Conversely, Taylor, Preshaw, & Lalla (2013), in a review of the evidence for 
pathogenic mechanisms that may link periodontitis and diabetes, explore the roles of 
cytokines and metabolic molecules (glucose and lipids) and periodontal bacteria. They 
conclude although diabetes results in metabolic dysregulation, hyperglycemia, and 
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chronic inflammation impacting tissue integrity and repair, the periodontal microbiota 
appears unaltered by diabetes and there is little evidence it may influence glycemic 
control. The authors postulate the role of proinflammatory factors remains speculative 
and call for future longitudinal clinical studies using larger patient groups, integrated with 
studies of animal models and cells/tissues in vitro. 
 Both diabetes and periodontal disease are inflammation driven. Because of this, 
controlling inflammation is paramount in managing both diseases. The successful 
treatment of periodontal disease, performed by an RDH, reduces inflammation and 
therefore could help control HbA1c. In the same way, controlling HbA1c, under the 
guidance of a CDCES, could contribute to reduced inflammation in the gingiva. 
Interprofessional collaboration is needed to support interdisciplinary treatment in 
controlling inflammation associated with these two diseases.  
Certified Diabetes Care Education Specialists (CDCES) 
 Individuals with diabetes learn to manage their disease through diabetes self-
management training or diabetes education in a collaborative process led by diabetes 
educators. A CDCES is a healthcare professional who has met eligibility requirements 
and passed a rigorous exam to become certified. Prior to 2020 these healthcare 
professionals were known as Certified Diabetes Educators or CDE. For purposes of 
clarity, this literature review uses the CDCES when referring to the former CDE. The 
National Certification Board for Diabetes Educators (NCBDE) and the CDCES credential 
were established in 1986 and are considered the standard of excellence for quality 
education and certification for those providing direct care to individuals with diabetes. 
Prior to taking the certification exam, professional experience working in the diabetes 
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education field is required. To maintain this credential, CDCES are required to stay up to 
date on the latest in prediabetes and diabetes care by obtaining a specific amount of 
continuing education credits. The NCBDE (2019) list the following eligibility 
requirements that must be met prior to testing: 
A. Bachelor’s degree at a minimum and current, active, and unrestricted licensure 
B. Registration /Certificates 
o Dietitian or dietitian nutritionists holding active registration with the 
Commission on Dietetic Registration 
o Physician Assistant holding active certification with the National 
Commission on Certification of Physician Assistants 
o Exercise physiologist holding active certification as an American College 
of Sports Medicine Certified Clinical Exercise Physiologist 
o Health educator holding active certification as a Master Certified Health 
Education Specialist from the National Commission for Health Education 
Credentialing  
C. Health care professionals with a minimum of a master’s degree in social work 
from a United States college or university accredited by a nationally 
recognized regional accrediting body.  
1. Professional Practice Experience (after meeting the Discipline Requirement) 
A. Minimum of 2 years of professional practice experience in the discipline 
under which the individual is applying for certification 
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B. Minimum of 1,000 hours of diabetes education experience earned within 4 
years of application date, with a minimum of 40% of those hours occurred in 
the most recent year preceding application. 
2. Continuing Education 
A. A minimum of 15 clock hours of continuing education (CE) activities 
applicable to diabetes is required prior to sitting for the exam. The CE must be 
earned and approved by a provider on the NCBDE List of Recognized 
Providers  
 The three most common healthcare providers to hold the CDCES credential are 
nurses (49%), registered dieticians (41%), and pharmacists (7%). CDCES work in varied 
settings, including hospitals, clinics, small practices, wellness centers, pharmacies, and 
for diabetes technology and medical device companies (Massey, 2019). The role of the 
CDCES can vary depending on the work environment. CDCES possess comprehensive 
knowledge of and experience in diabetes prevention, prediabetes, and diabetes 
management. They educate, support, and advocate for people affected by diabetes. The 
CDCES promotes self-management to achieve individual behavior and treatment goals 
that reduce risks and optimize health outcomes. They address the unique aspects of the 
individual’s life that impact diabetes care such as adjustments in diet, physical activity, 
blood glucose monitoring, medication dosing, and stress management (ADA, 2019). 
Therefore, CDCES are positioned to partner with other healthcare professionals in 
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Barriers to Interprofessional Collaboration  
 Lopes, Southerland, Buse, Malone, and Wilder (2012) conducted a qualitative 
study to identify the knowledge, opinions, and behaviors of CDCES (n=298). A 33-item 
questionnaire, consisting of open and close-ended and Likert-scale, was used to gather 
data. It was determined that of participating CDCES, 62% recognize the need for 
collaboration with dental professionals and 64% referred a patient to the dentist in the last 
year; 79% have not received formal oral health education, while 84% are interested in an 
oral health component in continuing education; 51% discussed oral health with their 
patients; and 20% felt confident in providing oral health screening to their patients. The 
authors call for further studies to determine the most effective method to educate CDCES 
about periodontal disease and diabetes and to determine if increased oral health 
information impacts their patients.                                                                    
 Similarly, a systemic search of five data bases was undertaken by Poudel, 
Griffiths, Wong, Arora, and George (2017) to provide a snapshot of the role of diabetes 
care providers and non-dental professionals in oral health care and management of 
individuals with diabetes. Relevant studies published through October 2016 were 
included (n=30) with no restrictions on the study design, quality, or setting. The focus of 
this study was to examine evidence on the knowledge and practices of diabetes care 
providers in oral healthcare/management of individuals with diabetes and to examine the 
role of non-dental professionals in oral health promotion. The results of this review 
determine diabetes care providers are not addressing oral health due to time constraints 
and limited oral health knowledge. The researchers call for future studies to identify 
barriers and resources to support diabetes educators in promoting oral health. 
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 Additionally, a qualitative study was conducted by Bissett, Stone, Ripley, and 
Preshaw (2013) to explore knowledge and attitudes regarding the links between diabetes 
and periodontitis of medical and dental healthcare professions as well as those of 
individuals with diabetes. Participants in this study included individuals with diabetes 
(n=4), dental professionals (n=4), general practitioners (GP) with a specialist interest in 
diabetes (n=3), GP without a special interest in diabetes (n=1), diabetic nurse specialists 
(n=3), and consultant diabetologists (n=2). Four inter-related themes relative to 
knowledge emerged from this study: 1) Uncertain knowledge regarding the links between 
periodontitis and diabetes 2) Unworkable knowledge regarding the differing medical and 
dental operating systems the healthcare professionals work in 3) Isolated knowledge or 
the perceived division that exists between medical and dental professions that could 
negatively impact advances in diabetes care and 4) The patient simply wanted the same 
consistent message from healthcare providers and help accessing dental care as needed. 
The authors call for future research to identify barriers to interprofessional collaborative 
care and to establish effective ways to implement change.  
Summary  
 Diabetes and periodontal disease are inflammation driven diseases. They are 
common and complex conditions. The relationship between diabetes and periodontal 
disease may be explained in terms of glycemic control and the severity of periodontal 
disease, and the inference can be made individuals with diabetes are likely to have 
periodontal disease and vice versa. Researchers agree additional studies are needed to 
further understand the mechanisms linking these two conditions. Emerging evidence 
supports the concept that periodontal infection adversely affects glycemic control and 
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poor glycemic control affects the periodontium; however, future randomized clinical 
trials employing robust methods with longer term follow-up and larger number of 
participants are needed to confirm and strengthen the current evidence. Researchers 
conclude, future studies are needed to evaluate substantiated periodontal therapies 
regarding DM2 and HbA1c. They also call for future studies to identify the barriers and 
possible oral health resources needed to support the CDCES in partnering with dental 
professionals to provide total patient care. 
 Periodontal therapy may help reduce and control glycemic levels. Similarly, 
improved glycemic control may help improve periodontal disease. Glycemic control 
(HbA1c) is potentially impacted by periodontitis, increasing the risks of other diabetic 
complications, thus, it is important to include the treatment of periodontal disease as an 
integral element of diabetes care. 
























Research Method or Design  
This pilot study looked at a point of care Periodontal Screening Tool to evaluate 
and promote periodontal care. This was a descriptive study with an exploratory design. 
A mixed methods approach gathered qualitative and quantitative data. The quantitative 
design allowed for the reporting of frequencies, averages, and percentages and the 
qualitative method determined opinions and attitudes. A demographic survey, pre-test, 
post-test, Education and Training Module, and Periodontal Screening Tool were used to 
answer the following questions: 1) Did a Periodontal Screening Tool, accompanied by 
training on how to use this tool, increase CDCES’s confidence in informing the patients 
on periodontal disease risk factors? and 2) Did the CDCES’s confidence result in 
providing resources for their patient to seek dental care? 
Procedures  
Human Subjects’ Protection/Informed Consent    
The Eastern Washington University (EWU) Institutional Review Board (IRB) 
approved this research. Participating educators signed consent (see Appendix A) prior to 
completing a pre-test (see Appendix B). CDCES from Kootenai Health, Coeur d’Alene, 
Idaho, and Providence Medical, Spokane, Washington, participated.  
Participant consent and pre-test were emailed to the Kootenai Health Diabetes 
Care Coordinator for distribution to Kootenai Health CDCES. Signed consent forms and 
completed pre-tests were electronically returned to the PI. At the conclusion of this study 
participants completed a post-test (see Appendix E) delivered via the participant’s email 
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and electronically returned to the PI, while CDCES from Providence Medical were sent a 
link for SurveyMonkey via their email to access participant consent and pre-test. At the 
conclusion of this study, a SurveyMonkey link was provided to access the post-test.  
Participation in this study was voluntary and participants could withdraw at any 
time. Any risks associated with this study were minimal and did not exceed those 
encountered in daily life. It is unlikely the CDCES received direct benefits from their 
participation in this study. All data collected from the pre- and post-tests and completed 
Periodontal Screening Tools was kept confidential on a password protected personal 
computer that only the PI (student) had access to and was shared only with the 
statistician. The participant’s personal information from this study remains confidential.  
At the completion of the study, the hard copies were scanned onto a thumb drive and will 
be kept in a safe, at the PI’s residence, for five years. After the thesis defense, the hard 
copies were shredded and disposed.  
Sample source, plan, sample size, description of setting.   
For pragmatic purposes, CDCES currently employed by Kootenai Health and 
Providence Medical were invited to participate in this study. As an incentive, participants 
were entered in a drawing for a Sonicare Toothbrush. This study coincided with diabetes 
counseling sessions provided in the clinical setting at Kootenai Health and Providence 
Sacred Heart Medical Center. Kootenai Health employs three CDCES, of which all three 
chose to participate. On a weekly rotation, due to COVID restrictions, two of three 
CDCES work remotely, while the third works in the Diabetes and Endocrinology clinical 
setting. Providence Medical employs three CDCES who work in several locations. One 
CDCES working in the clinical setting at Diabetes and Endocrinology in Providence 
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Sacred Heart Medical Center was recruited and chose to participate. The duration of this 
study was two weeks.  
Sample size for the qualitative data was determined by the number of CDCES 
who enrolled in the study. For quantitative data gathering, the number of times the 
CDCES completed the Periodontal Screening Tool and provided the resource list for the 
patient to seek a dental provider during the two-week study was tracked. Given that four 
CDCES see approximately 100 patients per month, with a 50% response rate, a 5% 
margin of error, and 95% confidence level, 66 completed Screening Tools was needed for 
statistical significance.  
This study was conducted in person using a hard copy Periodontal Screening Tool 
and patient demographic survey. The hard copy was chosen because it did not become 
part of the patient’s medical record and for ease of use; thus, the potential for a greater 
response.  
Variables   
  The independent variable was the Periodontal Screening Tool developed by the PI 
as an assessment tool for periodontal disease risk factors. The dependent variables were 
the CDCES’s confidence in informing their patients on periodontal disease risk factors 
and the number of times the CDCESs provided dental care resources to their patients. 
These were measured via post-test at the conclusion of the study period.  
Instruments  
 The instruments used for this pilot study were developed by the PI and include: 
Periodontal Screening Tool, pre-test, post-test, and an on-line Education and Training 
Module. 
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The Periodontal Screening Tool was developed as a periodontal risk factor tool 
for CDCES to use and includes a demographic survey to gather data regarding the 
patient’s dental history, a list of risk factors, a decision tree for recommending dental care 
as well as a resource list for the patient (see Appendix D). Based on research, several 
factors contribute to periodontal disease, including, but not limited to, poor oral hygiene, 
genetic susceptibility, medications, smoking, and systemic diseases. Content validity was 
achieved by using evidence-based resources for determining risk factors and reviewed by 
seasoned practitioners.  The PI formulated the questions that could be easily answered 
with yes or no and were appropriate for the diabetic patient. This instrument contained no 
patient identifiers and was limited to seven questions to ensure utility and frequency of 
use. It was delivered by the PI as hard copy to the CDCES. 
The pre-test consisted of a survey designed to gather CDCES demographic 
information and Likert-type questions to measure the current confidence level in 
informing their patients on periodontal risk factors and recommending dental care (see 
Appendix B). The post-test included the same Likert-type questions as the pre-test, with 
the addition of open-ended and close-ended questions and was designed to measure the 
perceived effectiveness of the Periodontal Screening Tool. A Likert scale numbered 1-5 
in equal intervals was used to rank confidence levels. Number 1 represented not at all 
confident and 5 represented extremely confident (see Appendix E). The pre- and post-
tests were designed to be accessed online as well as hand delivered.  
The Education and Training Module was created as an orientation to the 
periodontal diabetes link and periodontal risk factors. It also provided instruction for 
using the Periodontal Screening Tool. Information used in this module was founded on 
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evidence-based research and reviewed by the thesis committee. This module consisted of 
a 26 slide PowerPoint lecture and was delivered via Zoom prior to using the tool (see 
Appendix C).  
Equipment   
Minimal equipment was used for this study. CDCES used their work computer or 
personal computers to access the surveys and to participate in the Zoom conference for 
the Education and Training Module.  
Steps to Implementation  
  The following steps were completed for this study upon EWU IRB approval.  
 Step 1. Enrollment. The PI communicated with the Diabetes Care Coordinators 
at Kootenai Health and Providence Medical to generate interest and discuss enrolling 
CDCES in the study.   
Step 2. Consent and Pre-test. Once interest was established, the Participant 
Consent Document and Pre-test Survey were emailed to the participants through 
SurveyMonkey. SurveyMonkey uses two methods for tracking responses: through 
SurveyMonkey using participant’s email address or through a shared link. Because three 
participants were from Kootenai Health and the PI needed to compare pre- and post-test, 
tracking responses based on email address was used. Due to technical security measures 
associated with Kootenai Health and Providence Medical the invite from SurveyMonkey 
was not delivered. As an alternative method the PI emailed the Participant Consent 
document and Pre-test Survey to the Kootenai Health Diabetes Care Coordinator, who 
then printed and distributed them to the CDCES. Those who elected to participate signed 
consent (see Appendix A) and completed a Demographic Survey and pre-test (see 
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Appendix B) that was electronically returned to the PI. Because there was only one 
participant from Providence Medical, the PI directly emailed the shared SurveyMonkey 
link.  
Step 3. Education and Training Module. Participants attended the required 
Education and Training Module (see Appendix C) via Zoom prior to using the 
Periodontal Screening Tool (see Appendix D). 
Step 4. Data Gathering. The hard copy, one-page, Periodontal Screening Tool 
was hand delivered to the CDCES at the Diabetes and Endocrinology Clinics at Kootenai 
Health and Providence Sacred Heart Medical Center. The Periodontal Screening Tool 
was used as an adjunct to counseling. If there were any “yes” answers for periodontal risk 
factors in the first section of the one-page Screening Tool, the CDCES completed the 
Patient Survey in the second section to determine if the patient has a dental home and if 
not, off the tear-off resource list provided. Completed Periodontal Screening Tools were 
kept in a designated folder and stored in a sealed envelope for weekly pick-up by the PI. 
Step 5. Post-test. A post-test (see Appendix E), designed to evaluate the 
perceived effectiveness of the Periodontal Screening Tool, was sent via the participant’s 
email following two weeks of data collection. The completed post-test was electronically 
returned to the PI.  
Step 6. Data Analysis and Management. The PI collected the completed 
Periodontal Screening Tools weekly. Data from the Periodontal Screening Tool, pre- and 
post-tests, and demographics were entered into a Microsoft Excel worksheet for analysis. 
The online platform provided ease of access for data collection and analysis. All data 
collected from the pre- and post-tests and Periodontal Screening Tools was kept  
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confidential on the PI’s personal password protected computer and only the PI and a 
statistician had access to the information. The identity of all participants remains 
confidential. At the completion of the study, the hard copies were scanned onto a thumb 
drive and will be kept in a safe at the PI’s residence for five years. Hard copies were 
shredded and disposed of. All data was kept on a password protected computer that only 
the PI had access to.  
Summary 
Individuals with uncontrolled diabetes are likely to have periodontal disease and 
vice versa. For this reason, collaboration between medical and dental professionals is 
essential in the care and treatment of the diabetic patient. Providing a Periodontal 
Screening Tool together with an Education and Training Module as an orientation to the 
periodontal diabetes link and introducing periodontal risk factors, could increase 
confidence among CDCES in informing their patients on periodontal risk factors and 
recommending dental care. Introducing a Screening Tool for periodontal disease risk 
factors for non-dental professionals could translate to individuals with poorly controlled 
diabetes seeing the dentist or dental hygienist for evaluation and treatment.     
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 The aim of the study was to determine the effect of using a Periodontal Screening 
Tool on CDCES’s confidence in informing their patients on periodontal risk factors and 
providing resources for the patient to seek dental care. 
Description of Sample  
For pragmatic purposes, CDCES employed by Kootenai Health and Providence 
Medical were recruited to participate in this research. The results gathered from a 
convenience sample of CDCES were used to determine if using a Periodontal Screening 
Tool, accompanied by a training on how to use the tool, increases the CDCES’s 
confidence in informing their patients on periodontal disease risk factors and results in 
providing resources for the patient to seek dental dare. Kootenai Health Diabetes and 
Endocrinology employs three CDCES, of which all consented to participate. One CDCES 
working at Diabetes and Endocrinology at Providence Sacred Heart Medical Center also 
consented to participate.  
A total of four (n=4) participants completed this study. Based on demographic 
questions, two participants are between the ages of 25 and 34 years of age, one 
participant is between 45 and 54 years old, and one participant is between 55 and 64 
years old. All participants are female and in addition to being CDCES, they are 
Registered Dietitians. All participants practice in a specialty office and three also work in 
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the hospital setting. Two participants have been providing counseling between 6 and 10 
years while the other two have been providing counseling between 21and 25 years. The 
number of hours per week providing services was equally split between 16 to 20 hours 
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Statistical Analysis  
After completing the pre-test, the CDCES participated in an Education and 
Training Module on the oral-systemic link between diabetes and periodontal disease, 
periodontal disease risk factors, and use of the Periodontal Screening Tool. After using 
the Periodontal Screening Tool for two weeks, the CDCES completed the post-test, 
which was identical to the pre-test with the addition of three close-ended and two open-
ended questions. The number of times the CDCES completed the Periodontal Screening 
Tool and number of times they provided the resource list for the patient to seek a dental 
provider during the two-week study period were tracked. Given that 88 patients were 
seen in two weeks, with a 50% response rate, a 5% margin of error, and 95% confidence 
level, 33 completed Periodontal Screening Tools were needed for statistical significance. 
A total of 88 patients were seen during the two-week study period and the Periodontal 
Screening Tool was used 26 times (29.5%). Of the 26 completed Periodontal Screening 
Tools, a total of 5 resource lists (19%) were given to the client. Therefore, the power of 
this study fell below the optimal power needed to achieve significance. 
First research question 
To answer the research question, Did a Periodontal Screening Tool accompanied 
by training on how to use this tool increase CDCES’s confidence in informing the 
patients on periodontal disease risk factors, a paired two tailed t-test was used to 
compare the pre- and post-test data.  
For the pre- and post-test this study found a p-value of 0.15 using a paired two 
sample t-test. This means the probability of random error is .15 or 15%. Thus, the 
probability that the intervention caused the change in the pre- and post-tests is 85%. A 
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95% C.I. for the difference between the pre- and post-test means is (-2.032), (8.032). The 
probability the intervention caused the change between the pre- and post-test is not 
significant; however, because the p-value is 0.15, a greater sample size has the potential 
to increase the power to a point where significance is attained. Thus, the findings of this 
study likely have created a Type 2 Error, meaning a significance was not achieved where 




Average Likert-scale Comparison 
 
pre   post   difference 
Mean 15.75  Mean 18.75  Mean 3 
Standard Error 1.75  Standard Error 1.38  Standard Error 1.58 
Standard 
Deviation 3.5  
Standard 




Variance 12.25  
Sample 
Variance 7.583  
Sample 
Variance 10 
Maximum 20  Maximum 22  Maximum 6 
Count 4  Count 4  Count 4 
Confidence 
Level (95.0%) 5.57  
Confidence 
Level (95.0%) 4.38  
Confidence 
Level (95.0%) 5.03 
CI 95% Below 10.18   14.37   -2.03 
CI 95% Above 21.32     23.13     8.03 
 Descriptive statistics for pre- and post-test 
 
A Pearson Correlation was done for the pre- and post-tests. The r = 0.51 indicates 
that the correlation is moderate and positive. With a larger sample size, this correlation is 
likely to change dramatically. The correlation r-value and p-value for pre- and post-test 








t-Test: Paired Two Sample for Means 
 
  pre post 
Mean 15.75 18.75 
Variance 12.25 7.58 
Observations 4 4 
Pearson Correlation 0.51  
t Stat -1.9  
P(T<=t) two-tail 0.15   
Significance was set at the p-value < 0.05. 
 
Likert-scale data from five questions, as well as qualitative data from three yes/no 
questions and two open-ended questions, were gathered and analyzed. Table 6 shows 
whether the change in pre- and post-test scores was a result of the Periodontal Screening 
Tool or random error. The p-value indicates the probability that the change was the result 
of the Periodontal Screening Tool or random error. A low p-value indicates there is a 
strong probability the difference noted was the result of the Periodontal Screening Tool 
accompanied by Education and Training Module rather than random error. A correlation 






















Pre-test and Post-test Likert-scale Questions 
________________________________________________________________________ 
Survey Question  Response   Paired two tailed Pearson Correlation             
      difference   t-test p-value = 0.15        r-value = 0.51       
  
Q1 How confident are you  
counseling the patient  
about oral health  4 points  .092   .150   
 
Q2 How confident are you  
in your knowledge about  
periodontal disease  2 points  .182   .818   
 
Q3 How confident are you  
in your knowledge of the  
bidirectional relationship  
between diabetes and  
periodontal disease  2 points  .182   .333   
 
Q4 How confident are you  
in educating the patient  
about periodontal disease 2 points  .495   .000   
 
Q5 How confident are you  
recommending the patient  
see the dentist or dental  
hygienist for a periodontal  
evaluation   2 points  .182   .818   
Note. p-value = 0.05 
 
Note. r-value no correlation = .000, correlation ± .001 to .300 = weak,  
± .301 to .700 = moderate, ± .701 to 1.000 = strong  
 
The following provides further explanation per the initial five questions: Q1, Q2, 
Q3, Q4, and Q5 on the pre-test and post-test per item analysis.  
Q1 The paired two tailed t-test p-value is .092. Thus, there is a high probability (91%) the 
change noted is the result of the Periodontal Screening Tool rather than random error. 
The Pearson Correlation r-value is .150, indicating a weak correlation.  
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Q2 The paired two tailed t-test p-value is .182. Thus, there is an 82% probability the 
change noted is a result of the Periodontal Screening Tool rather than random error. The 
Pearson Correlation r-value is .818, indicating a strong correlation.  
Q3 The paired two tailed t-test p-value is .182. Thus, there is an 82% probability the 
change noted is a result of the Periodontal Screening Tool rather than random error. The 
Pearson Correlation r-value is .333, indicating a moderate correlation.  
Q4 The paired two tailed t-test p-value is .495. There is a 50% probability that the change 
noted was not the result of the intervention, meaning there is strong probability it was due 
to random error. The Pearson Correlation r-value is .000, therefore, no correlation exists.  
Q5 The paired two tailed t-test p-value is .182. Thus, there is an 82% probability the 
change noted is a result of the Periodontal Screening Tool rather than random error. The 
Pearson Correlation r-value is .818, indicating a strong correlation.  
The post-test included three close-ended questions, Q6, Q7, and Q8, as well as 
two open-ended questions, Q9 and Q10. All CDCES reported using the Periodontal 
Screening Tool increased their confidence in recommending patient for dental care. They 
also reported training on the use of the Periodontal Screening tool was adequate. Fifty 
percent of the CDCES would be likely to implement a periodontal risk factor evaluation 
















 Responses to Close-ended Questions 
________________________________________________________________________ 
Survey Question     Yes No %    
 
Q6. Did using the Periodontal Screening    4  0 100 
Tool increase your confidence in 
recommending patient for dental treatment?         
 
Q7. Was training on the use of the Periodontal  4 0 100 
 Screening Tool adequate?                                                 
 
Q8. Would you be likely to implement a   2 2 50 
periodontal risk factor evaluation tool  
such as the Periodontal Screening Tool  
into your practice?            
Note. (N=4)  
 
The qualitative data gathered from the two open-ended questions, Q9 and Q10, 
was evaluated with content and narrative analysis focusing on themes that were 
frequently present in CDCES’s answers.  
When asked, What about the Periodontal Screening Tool was helpful, 50% 
reported it opened the conversation and provided a segue into discussing oral health, 25% 
reported ease of use and resources provided, while 25% reported it was a useful reminder. 
When asked for suggestions on what they thought would make the Periodontal Screening 
Tool stronger, 25% suggested a shorter version, 25% replied “some of the questions 
could be clearer,” 25% suggested more resources, and 25% felt it was very strong and 
had no suggestions. Figure 10 provides the CDCES’s responses to the open-ended 











Responses to Open-ended Questions       
 
Q9. What about the Periodontal 
Screening Tool was helpful? 
Q10. What addition(s) to the 
Periodontal Screening Tool would 
make it stronger? 
“Was a great icebreaker for patients and 
easy segue into speaking about oral 
health.” 
 
“I would actually make it a little shorter.” 




“It opened the conversation to care 
guidelines, the client's regimen/care, and 
resources.” 
 
“It seems very strong, I don't have any 
suggestions.” 
“Mostly as a reminder” 
 
“Some of the questions could be clearer.” 
Note. Respondents’ full answers in quotes (N=4) 
 
Second research question 
 
To answer the research question, Did the CDCES’s confidence result in providing 
resources for their patient to seek dental care, descriptive statistics were used. Data 
gathered from the completed Periodontal Screening Tools (n=26) indicates that several 
patients were not at risk for periodontal disease (35%). The patient demographic data 
indicated the majority of patients (95%) have a dental home and were not referred by 
their medical professional (95%). One patient who did not have a dental home and was 
referred by their medical provider, reported they were unable to find a dentist who 
would accept Medicaid.  Five resource lists were given to the patients to seek dental care 















Results from this study demonstrate the use of a Periodontal Screening Tool with 
an Education and Training Module resulted in increased confidence in informing the patient 
about periodontal disease risk factors and providing resources to seek dental care. A strong 
correlation was found between the pre- and post-test scores. One hundred percent of the 
CDCES reported using the Periodontal Screening Tool increased their confidence in 
recommending patient for dental care. These results indicate the sample size (n=4) is not 
large enough to determine statistical significance; however, findings suggest this pilot 
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Referred by medical provider
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Summary of Major Findings  
The results of this Pilot Study indicate using a Periodontal Screening Tool, 
accompanied by education and training on how to use it, increased the CDCES’ 
confidence level when informing the patient on periodontal disease risk factors and 
resulted in providing resources to seek dental care. Prior to using the Periodontal 
Screening tool, the CDCES attended an Education and Training Module focusing on the 
periodontal-diabetes link, periodontal risk factors, and instruction for use. During the 
two-week study period, CDCES incorporated the Periodontal Screening Tool as an 
adjunct to counseling. A total of 88 patients were seen during the study period. There 
were 26 completed Periodontal Screening Tools and 5 resource lists given. By comparing 
their confidence levels before and after using the Periodontal Screening Tool it was 
evident this non-dental screening tool had a positive influence on perceived confidence. 
Discussion of these results are organized around the research questions.  
Discussion   
Research question #1: Did a Periodontal Screening Tool accompanied by training on 
how to use this tool, increase CDCES’s confidence in informing the patient on 
periodontal disease risk factors? 
The results of the pre- and post-test five Likert scale scores on the CDCES’ 
confidence demonstrate an overall increase in confidence in informing the patients on 
periodontal disease risk factors however, areas of improvement exist. There were two 
CDCES who have practiced for 25+ years and reported little change between pre-test and 
post-test scores. Perhaps this is due to longevity in the workplace and the need for 
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Continuing Education (CE) requirements. Several topics for CE are available and could 
include periodontal disease and the oral systemic link; therefore, these participants may 
have already had knowledge of the correlation between diabetes and periodontal disease.   
Regarding Q1, CDCES were confident counseling the patients about oral health 
prior to participating in the Education and Training Module and using the Periodontal 
Screening Tool. The Pearson Correlation r-value of 0.150 indicates the ability to predict 
the post score based on the pre score is weak. There could be several possibilities for why 
this relationship was weak. One possibility is CDCES with more experience already 
educate patients about the long-term negative consequences of uncontrolled diabetes. 
Their training includes oral manifestations associated with diabetes which may account 
for their confidence prior to implementing this study.   
Findings about confidence from Q2 knowledge of periodontal disease, Q3 
bidirectional relationship between diabetes and periodontal disease, and Q5 
recommending or referring a patient for a periodontal evaluation show a moderate to 
strong correlation between the pre- and post-test and indicate there is an 82% probability 
the change noted is a result of using the Periodontal Screening Tool. In the Education and 
Training Module the PI informed the CDCES on the diabetes-periodontal disease link 
and periodontal disease risk factors in addition to use of the Periodontal Screening Tool. 
Two CDCES reported an increase in perceived confidence for Q1, Q2, Q3, Q4, and Q5; 
however, combined they used the screening tool seven times and neither one shared the 
resource list with the patient. Based on their number of Periodontal Screening Tools 
completed, it seems the increase in confidence may have been the result of the Education 
and Training Module rather than the experience of using the Periodontal Screening Tool. 
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This point is meaningful and speaks to the need for education on the oral systemic link, 
the need for more inter-professional education (IPE), and inter-professional collaboration 
(IPC).  
In contrast, the findings from Q4 regarding confidence in educating the patient 
about periodontal disease, indicate the change noted was not the result of the Periodontal 
Screening Tool. The results show little change between the pre and post-test scores with 
no correlation; meaning, educating the patient on periodontal disease may still be 
uncomfortable for CDCES. Developing a Periodontal Education Aid for the CDCES to 
use could increase their confidence in doing so. For example, a YouTube link to the 
module, a podcast as a review of how to use the Periodontal Screening Tool, a two-sided 
laminated diagram with the Periodontal Screening Tool on one side, and graphics, 
weblinks, and quick references on the other side for the CDCES. 
There were two CDCES who have practiced for 25+ years and reported little 
change between pre-test and post-test scores. This may be due to longevity in the 
workplace and the need for yearly Continuing Education (CE) requirements. Several 
topics for CE are available and could include periodontal disease and the oral systemic 
link.    
Results from this study showed comparable findings to research conducted by 
Lopes, et al., (2012), who found 20% of participating CDCES felt confident in providing 
oral health screening to their patients, 51% discussed oral health with their patients, and 
64% referred a patient to the dentist in the last year.  Furthermore, this study indicates a 
need for ongoing education about periodontal disease for CDCES which aligns with 
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findings from Poudel, et al., (2017) who identified limited oral health knowledge and the 
effect this has on the management of individuals with diabetes.  
When answering the three close-ended questions and two open ended questions, 
these CDCES reported using the Periodontal Screening Tool increased their confidence 
in recommending patient for dental care. They also reported training on the use of the 
Periodontal Screening Tool was adequate. When asked which aspects of the Periodontal 
Screening Tool were helpful, 50% reported it opened the conversation and provided a 
segue into discussing oral health, while 25% reported it was easy to use. The CDCES saw 
value in the Periodontal Screening Tool and 50% would be likely to implement a 
periodontal risk factor evaluation tool into their practice. This is meaningful because it 
indicates they are going to use it and most importantly, it has the potential of benefitting 
the patient.  
Although this sample size is small for statistical analysis, the qualitative answers 
provided helpful recommendations for strengthening the Periodontal Screening Tool. 
When asked for suggestions on what would make the Periodontal Screening Tool 
stronger, 25% commented that it was strong as it is, while 75% had specific comments 
for changes.  
It was suggested the Periodontal Screening Tool be shorter, more concise, and 
provide more resources. Revising the questions for more clarity in the patient’s dental 
history may have provided valuable information regarding the patient’s knowledge about 
why it is important to see the dentist when diagnosed with diabetes. For example, the first 
question asked was Do you have a dental home followed by If yes, were you referred by 
your medical professional.  It was interesting to learn most patients (95%) had a dental 
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home; however, only one was referred by their medical professional. Perhaps a better 
question might have been Did your medical provider inform you about the systemic link 
between diabetes and periodontal disease and the need to see the dentist for an 
evaluation. Asking the question differently could highlight the need for practitioners to 
initiate that conversation and the importance of recommending dental care.  
Research question #2: Did the CDCES’s confidence result in providing resources for 
the patient(s) to seek dental care? 
Five resource lists were given. One CDCES was responsible for 100% of the 
resource lists that were shared. She also used the Periodontal Screening Tool 58% 
compared to a combined 42% for the other CDCES. It seems the more times the 
Periodontal Screening Tool is used, more opportunities are provided for sharing the 
resource list.   
Compared to total number of patients seen (N = 88), only 26 Periodontal 
Screening Tools (n=26) were used. This number seems small due to an assumption that 
there would more opportunities to use the Periodontal Screening Tool. This could be a 
result of the type of counseling appointment. Patients seen strictly for instruction on 
medication and use of the insulin pump were not candidates for using the Periodontal 
Screening Tool. A problem with the methodology was not tracking how many 
appointments were strictly medication use and insulin pump instruction. Future research 
should exclude patients being counselled only for medication use and insulin pump 
instruction.  
The Periodontal Screening Tool was designed as adjunct to education and training 
for the CDCES’s use. It included a demographic survey to gather data regarding the 
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patient’s dental history, a decision tree for recommending dental care, and a resource list. 
If there were any “yes” answers for periodontal risk factors in the first section of the one-
page Periodontal Screening Tool, the CDCES completed the patient survey in the second 
section to determine if the patient had a dental home and if not, provide the tear-off 
resource list. The results from this survey indicate 6 patients (35%) answered “no” to all 
questions in the first section; therefore, the CDCES did not complete the dental history, 
thus did not share the resource list. It was assumed by the PI that only individuals with 
uncontrolled Type 2 diabetes were referred for counseling. The results of this study 
showed individuals with well-controlled blood sugar levels also receive counseling.  
The second half of the Periodontal Screening Tool consisted of a patient survey 
designed to discover the patient’s dental history, identify possible barriers to care, and 
provide resources to seek dental care. Twenty-six Periodontal Screening Tools were 
completed and of those, only five resource lists were given. It was assumed that medical 
providers who diagnose diabetes do not refer their patients to the dentist for a periodontal 
evaluation. It was interesting to learn most patients (95%) had a dental home; however, 
they were not referred by their medical professional. A possible reason could be that the 
patient had a dental home prior to being diagnosed with diabetes; therefore, they would 
not need a referral. One of the questions in the demographic patient survey was If you did 
not see the DDS, why not followed by a check list of choices including fear, expense, 
pain, unaware of the risks of gum disease, and other. There was one patient (5%) who did 
not have a dental home and was referred by their medical provider who answered, 
“Medicaid not accepted by most dentists.” From previous research on barriers to care, the 
PI was aware that many dentists limit the number of Medicaid patients they accept due to 
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the low reimbursement rates. For this reason, the two recommendation for dental care on 
the resource list were Eastern Washington University Dental Hygiene Clinic and North 
Idaho College Dental Hygiene Clinic, both of which accept Medicaid. When asked what 
would make the Periodontal Screening Tool stronger, 25% responded more resources, 
which should be considered going forward. Another interesting fact the PI had not 
accounted for was edentulous patients with diabetes. In this study, two patients (10%) 
wore dentures, which had an effect on the number of resource lists given.   
Implications of Research 
This study explored how diabetes and periodontal disease are related and how the 
treatment of one affects the other. The results of this research demonstrated that the 
Periodontal Screening Tool is a possible solution in connecting CDCES and Oral Health 
Care Professionals in support of each other in providing total patient care.  
Research shows that periodontal therapy (controlling inflammation caused by 
periodontal disease) increases the probability of controlling blood sugar levels, thus 
reducing the long-term complications associated with diabetes. This supports the goal of 
Healthy People 2030 to reduce the long-term complications associated with diabetes and 
increase the use of oral healthcare systems.  
Utilizing a Periodontal Screening Tool accompanied by an Education and 
Training Module, as described in this study, could play an integral part in gaining 
knowledge regarding the link between periodontal disease and other systemic diseases 
and help connect patients with oral health professionals. Professional health care 
organizations should consider promoting educational opportunities on topics such as the 
oral-systemic link and inter-professional collaborative care.  
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Many patients with systemic inflammatory diseases present with co-morbidities. 
Providing a Periodontal Screening Tool for all health care professionals who treat 
patients with systemic inflammatory diseases, such as diabetes, cardiovascular disease, 
and rheumatoid arthritis could increase inter-professional collaboration and result in 
overall healthier patient outcomes. Such a tool could have a major impact on the overall 
health of the patient with co-morbidities. Introducing a screening tool for periodontal risk 
factor assessment for non-dental professionals could translate to individuals with 
systemic inflammatory diseases seeing their Dentist, Dental Therapist, or Dental 
Hygienist for evaluation and treatment.     
Limitations   
The main limitation to this study was sample size. It has previously been 
recommended that qualitative studies require a minimum sample size of at least 12 to 
reach data saturation (Fugard & Potts, 2014). This is often a limitation for a Pilot Study.  
A total of four CDCES completed this study. The small sample size might produce biased 
results and the findings will be less conclusive. Recruiting CDCES from additional 
hospitals and clinics could have increased participation. The non-parametric convenience 
sample and lack of the control group limits the generalizability.  
Another limitation of this pilot study was the two-week study period. CDCES 
from Inland Northwest Health Services (INHS) were originally recruited for this study. 
Between recruiting, enrollment, and implementation of this study, INHS was acquired by 
Providence Medical. As a result, approval from Providence Medical Research Board was 
required prior to implementation. This process took three weeks in committee, which 
resulted in enrolling another group of CDCES to participate and shortened the duration of 
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this study from four weeks to two weeks. Extending the duration of the study would have 
provided more opportunities to use the Periodontal Screening Tool, which may have 
strengthened the results.   
The number of patients seen weekly and the number of completed Periodontal 
Screening Tools were tracked; however, many patients were counseled strictly on 
medications and insulin pump use. For this type of session, the use of the Periodontal 
Screening Tool was inappropriate. It may have been helpful to track how any counseling 
appointments were strictly medication use and insulin pump instruction.   
Another limitation of this study is the design of the Periodontal Screening Tool. 
For ease of use, it was a one-page document delivered as hard copy. The post-test 
findings indicate some of the questions need clarification and fewer items were 
suggested; thus, a shorter and more succinct tool may prove useful.  
Recommendations/Suggestions for Future Research  
The current study investigated the effect of a Periodontal Screening Tool, 
accompanied by an Education and Training Module, on CDCES’s confidence in 
informing the patient on periodontal disease risk factors and providing resources for the 
patient to seek dental care. The results of this pilot study demonstrated that a full-scale 
study is feasible. Suggestions to further this research are: 1) Utilize a larger sample size 
by recruiting all medical providers who see or treat patients with diabetes, 2) Include all 
settings where diabetes care and management take place and 3) Consider revising the 
Periodontal Screening Tool to make it more concise and increase clarity.  
One possibility for increasing the sample size and setting would be to include 
hospitalists, who see every patient admitted to the hospital, many of whom will have 
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diabetes. Upon initial intake, it would be determined whether the patient has been 
diagnosed with diabetes, which would present the opportunity to use the Periodontal 
Screening Tool. Revising the questions regarding the patient’s dental history could give 
insight to the conversation regarding the oral-systemic link. Additionally, data could have 
been addressed through focus groups of the CDCES providing a more qualitative piece. 
Another suggestion for future research would be to test the Periodontal Screening 
Tool as a way of perfecting it. Future research is needed to determine the most effective 
way to educate CDCES about periodontal disease and diabetes and to determine the 
impact of increased oral health education on their patients. An area of focus for the future 
would be to develop an educational module regarding the bidirectional relationship 
between inflammatory systemic diseases to further inter-professional education and 
support collaborative care. Implementing this module in an inter-professional healthcare 
setting as a professional development or continuing education course may prove 
particularly beneficial, as discussion and collaboration may occur. Future studies are 
needed to evaluate attitudes and perceptions regarding collaborative patient care, 
specifically between healthcare professionals who treat patients with inflammatory 
diseases. In addition, studies are needed to develop platforms from which to do this, such 









Diabetes affects an estimated 422 million adults worldwide and this number is 
expected to double or triple by 2050. Periodontal disease is the sixth most common 
complication of diabetes. Because the long-term complication associated with diabetes 
worsen over time, the need for collaborative care is evident. Periodontal therapy may 
help reduce and control glycemic levels. Similarly, improved glycemic control may help 
improve periodontal disease. Considering the potential impact of periodontitis on 
glycemic control, thus increasing the risks of other diabetic complications, it is 
paramount to include the treatment of periodontal disease as an integral element of 
diabetes care. This research demonstrated the importance of providing a user-friendly 
periodontal risk assessment tool for CDCES. Furthermore, this Periodontal Screening 
Tool could be used by other healthcare professionals who treat patients with systemic 
inflammatory diseases. Ultimately, this would increase inter-professional collaborative 
care and could result in overall healthier patient outcomes, which supports the objectives 
of Healthy People 2030 to reduce long-term complications associated with diabetes and 
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Participant Cover Letter  
 
Dear Diabetes Educators, 
 My name is Holly Brawner, and I am currently pursuing my Master of Science in 
Dental Hygiene degree at Eastern Washington University. I would like to invite you to 
participate in my thesis study titled A Pilot Study: Periodontal Risk Factor Evaluation 
Tool for Certified Diabetes Care and Education Specialists. I currently practice dental 
hygiene and live in Coeur d ‘Alene, Idaho. I am passionate about creating a bridge 
between the medical and dental communities which has led me to focus my thesis on this 
topic.  
 The purpose of this study is to test a periodontal disease risk assessment tool for 
non-dental professionals. This study looks at a point of care Periodontal Screening Tool 
to evaluate and promote periodontal care. This study will explore the periodontal diabetes 
link and how to best promote this phenomenon, so patients are provided the medical and 
dental care options when treating diabetes. It will explore inter-professional collaboration 
between the medical and dental communities, specifically Certified Diabetes Care and 
Education Specialists and Registered Dental Hygienists, as well as offer a possible 
solution in connecting healthcare providers in support of each other in providing total 
patient care. Providing a tool for periodontal disease risk assessment for CDCES and 
patients could translate to individuals with poorly controlled HbA1c seeing the dentist or 
dental hygienist for evaluation and treatment. Any risks associated with answering the 
questions are minimal and do not exceed those encountered in daily life. You are not 
likely to receive direct benefits from participating in this research study. However, your 
responses may help me learn more about promoting periodontal care among individuals 
with diabetes. In addition, the Principal Investigator (PI) hopes to identify possible 
barriers to dental care.   
 As part of this research, you are asked to complete a Participant Demographic 
Survey and Pre-test prior to participating in an Online Education and Training Module. 
This survey includes informed consent and can be accessed via your email through the 
SurveyMonkey link provided. This survey should take no more than 10 minutes to 
complete. The online Education and Training Module will consist of a PowerPoint 
presentation, lecture, and questions and answers. The 40-minute module will be presented 
via Zoom at an agreed upon time and date prior to implementing the use of the 
Periodontal Screening Tool and after pre-test submission. Participation in this study is 
voluntary. You may skip any question you do not want to answer for any reason. As an 
incentive, those who participate in the pre-test, post-test, and Education and Training 
Module will be entered in a drawing for a Sonicare Toothbrush.  
 The duration of this study will be two weeks where you will be asked to use a 
hard copy Periodontal Screening Tool to gather data for periodontal risk factors of each 
patient being counseled. The one-page Periodontal Screening Tool includes a 
demographic survey to gather data regarding the patient’s dental history, a list of risk 
factors, and a decision tree for recommending dental care. A tear-off resource list is 
included. When completed you will be asked to place them in an envelope for the PI to 
68 
PERIODONTAL RISK FACTOR EVALUATION TOOL 
 
pick-up. All data collected from the pre and post-tests and Periodontal Screening Tools 
will be kept confidential and only the PI (student) and a statistician will have access to 
the information. The identity of all participants will remain confidential. At the 
conclusion of this two-week study, you will be asked to complete an online post-test, 
identical to the pre-test, with the addition of close-ended and open-ended questions, 
which will be delivered via your email through the SurveyMonkey link provided. By 
answering the survey questions, you are stating you are at least 18 years of age or older 
and your consent to voluntarily participate in this research is implied. 
 
 ______Yes, I agree  Signature____________________________ 
  
 If you have any questions or concerns about this study, please contact Principal 
Investigator Holly Brawner at (509) 979-6287 or hbrawner@eagles.ewu.edu or Thesis 
Chair Ann O’Kelley Wetmore at awetmore@ewu.edu. If you have any concerns about 
your rights as a participant in this research or any complaints you wish to make, you may 
contact Charlene Alspach, Executive Director, Grant & Research Development, Eastern 





























Demographic Survey and Pre-test 
 
1. What is your age? 
____25-34     ____35-44     ____45-54    ____55-64     ____65 and older 
2. What is your gender?  
_____male      _____female      ____other      _____prefer not to answer 
3. What degree do you hold? 
_____Registered Nurse      _____Registered Dietitian      _____Pharmacist     
____Other  
If other, list profession___________________________________________ 
4. What is your practice setting? 
_____specialty office    _____hospital setting    ____private practice    ____other  
If other, list practice setting_______________________________________ 
5. How long have you provided counseling and educational services to patients with 
diabetes? 
_____under 1 year     _____1-5 years         ____6-10 years     ____11-15 years 
_____16-20 years      _____21-25 years    ____26 years and longer 
6. How many hours a week do you provide care to patients with diabetes? 
___ 1-5      ___6-10      ___11-15      ____16-20     ____21-25     ____26 and over 
Pre-test 
Please rank your confidence level 
1. How confident are you counseling the patient about oral health? 
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o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
2.  How confident are you in your knowledge about periodontal disease? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
3. How confident are you in your knowledge of the bidirectional relationship between 
diabetes and periodontal disease? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
4. How confident are you in educating the patient about periodontal disease? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
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o Not at all confident  
5. How confident are you recommending the patient see the dentist or dental hygienist for 
a periodontal evaluation? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident 
 
 





























































































































HbA1c 7.0 % or greater                      ___Yes ___No 
 
Family history of periodontal disease 
(gum disease, pyorrhea) mother, father,  
sibling with tooth loss)                                      ___Yes ___No 
 
Cigarette Smoker       ___Yes ___No 
   
Brushes less than once per day    ___Yes ___No 
     
Flossing less than once per day     ___Yes ___No  
    
Taking anticonvulsants, immunosuppressants,    
antihistamines, or narcotic analgesics    ___ Yes ___No 
   
Diagnosed cardiovascular disease  
or rheumatoid arthritis     ___Yes ___No  
_______________________________________________________________________ 
 
If there are any yes answers, please ask the patient the following questions:  
 
Patient Survey filled out by the CDE                                    
Do you have a dental home?     ___Yes ___No  
If yes,  
Were you referred to the dentist by a medical professional?  ___Yes ___No             
If not, will you accept a resource list?   ___Yes ___No 
Resource list given.       ___Yes ___No  
If you did not see the DDS, why not? 
 
Fear ___Pain ___Cost ___No Dental Home 
 
___Unawareness of Risk of Gum Disease ___Other 
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Tear-0ff Resource List  
 
  EWU Dental Hygiene Clinic  (509) 828-1300 
 







































Please rank your confidence level 
1. How confident are you counseling the patient about oral health? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
2.  How confident are you in your knowledge about periodontal disease? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
3. How confident are you in your knowledge of the bidirectional relationship between 
diabetes and periodontal disease? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
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4. How confident are you in educating the patient about periodontal disease? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident  
5. How confident are you recommending the patient see the dentist or dental hygienist for 
a periodontal evaluation? 
o Extremely confident  
o Very confident 
o Somewhat confident 
o Not so confident 
o Not at all confident 
6. Did using the Periodontal Screening Tool increase your confidence in recommending 
patient for dental treatment?  ____Yes      ____No 
7. Was training on the use of the Periodontal Screening Tool adequate? 
____Yes ____No 
8. Would you be likely to implement a periodontal risk factor evaluation tool such as the 
Periodontal Screening Tool into your practice?  ____Yes ____No 
 
 9. What about the Periodontal Screening Tool was helpful?  
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Shared SurveyMonkey link 































HOLLY J. BRAWNER, RDH, BSDH, MSDH (c) 
 
Phone (509)-979-6287   831 N 5th Street 
hollybrawner@yahoo.com   Coeur d’Alene, Idaho  





MS   Master of Science in Dental Hygiene  Anticipated 2021  
  Eastern Washington University  
  Thesis: Periodontal Disease Risk Factor Evaluation Tool 
 
BS  Bachelor of Science in Dental Hygiene 1983 
  Eastern Washington University 
 
 
PROFESSIONAL CERTIFICATS & LICENSURE 
 
Washington State Registered Dental Hygienist 
 License # 00002791 
 Expanded functions including: 
o Administering local anesthetic 
o Nitrous oxide/oxygen sedation 
o Placement of pit and fissure sealants 
o Placement of restorative materials 
   
 
CPR/AED Certification  
 
 
PROFESSIONAL SKILLS AND COMPETENCIES 
 
Proficient  
o Pezio and Cavitron Ultrasonic Scalers 
o The Wand Local Anesthetic Delivery System 
o Digital x-ray and Intra-oral camera 
Familiar  
o Dentrix and Eaglesoft Dental Software Systems 
Experience  
o Microsoft Word, Excel, PowerPoint and Outlook 
o Zoom Conferencing 
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EWU MSDH COURSE WORK and TEACHING EXPERIENCE 
 
         
EWU DH Adjunct Clinical Faculty   September 2019-present 
   
 Providing hands-on guidance  
 Socratic Questioning 
 Encouraging critical thinking skills 
 
DNHY 625 Clinical Teaching Strategies    August-December 2019 
 
Clinical Teaching Module 
EWU BSDH 
Motivational Interviewing 
Clinic Workshop  
Debrief Lecture  
 
DNHY 635 Teaching Practicum    January- May 2019 
  
 EWU BSDH (Junior Students) 
 Physiology, Pathology, and Pharmacology 
 Lecture: Endocrine Disorders: Diabetes and Periodontal Disease 
 Lecture: Infectious Endocarditis 
 Lecture: Cultural Sensitivity 
 
DNHY 505 Healthcare Leadership    August-December 2018 
 
Leadership Project 
Educational Module Presentation 
Stephen Mills DDS Spokane, Washington 
Medical Emergencies in the Dental Office  
 
DNHY 605 Components of Program Development January-April 2018 
 
Educational Program  
 Garfield Middle School 5th Grade Science Class 
 Garfield, Washington 
The Damaging Effects of Energy Drinks on Enamel 
 
Holmes Elementary Spokane, Washington   February 1990 
  
 Education and Interactive Learning   
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Northwest OBGYN Prenatal Class    May 1983 
 Educational Module 
 Developed and presented lecture and slide show 




     
Eastern Washington University      2019-Present 
 Adjunct Clinical Faculty  
 BSDH Program    
 
Robert R. Shaw DMD, Spokane, WA    2016-2019 
  Registered Dental Hygienist 
 Traditional and Expanded Duties  
    
Stephen H. Mills DDS, Spokane, WA    2009-2016  
 Registered Dental Hygienist 
 Traditional and Expanded Duties  
       
Robert R. Shaw DMD, Spokane, WA    2008-2010 
 Registered Dental Hygienist 
 Traditional and Expanded Duties  
      
Robert P. Parker Jr. DDS, Spokane, WA    1994-2007 
 Registered Dental Hygienist  
 Traditional and Expanded Duties 
        
Robert R. Shaw DMD, Spokane, WA    1985-1993 
 Registered Dental Hygienist 
 Traditional and Expanded Duties 
      
Robert E. Morrow DDS, Spokane, WA    1977-1979  
 Pediatric Dentistry 
 Dental Assistant 
 Lab Technician 
   
 
HONORS AND AWARDS 
 
Spokane District Dental Society Conference  1983 
Table Clinic Award 
Vertical Bitewings 
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PROFESSIONAL AFFILIATIONS 
American Dental Hygienists’ Association  1983-1990 
Inland Northwest Dental Hygiene Study Club 2011-2016 
American Dental Hygienists’ Association  2017-Present 
American Dental Education Association  2017-Present 
Eastern Washington University  2018-Present 
College of Health Science and Public Health 
Advisory Board 
COMMUNITY/VOLUNTEER SERVICE 
WSU Collaboration: Stephens County Project  October 2020 
Workshop: Mentoring the Mentor 
Guided undergraduate students in ways to effectively 
engage middle school students in hands-on learning  
opportunities for career choices in the health sciences 
EWU Admission Interviews  2019 
Conducted dental hygiene school candidate interviews 
Landmark Forum Worldwide: Family Division 2016 
Leadership Support 
Landmark Forum Worldwide 2017-2018 
Leadership Support 
The Rypien Foundation 2005-2010 
Annual Wine Maker’s Dinner 
Fundraising/Staging Auction Items 
PERSONAL GROWTH WORK
Landmark Worldwide Forum June 2015 
Graduate 
Landmark Worldwide  June 2016 
Advanced Course Forum 
87 
PERIODONTAL RISK FACTOR EVALUATION TOOL 
Graduate 
Landmark Worldwide July 2015 -Present 
Seminar Series: 
Group Leader  
Focusing in areas of relationship, communication,   
leadership, community, enrollment and empowerment. 
